BETHESDA, MD – Data integrity issues were the primary reason for the US Food and Drug Administration’s (FDA) delay in approving abbreviated new drug applications (ANDAs) past their review goal date, ...
The US Food and Drug Administration (FDA) has issued four warning letters to companies in China, India, and the US for various violations of good manufacturing practices (GMPs) related to the ...
In part 2 of a 2-part interview,Susan Schniepp, Regulatory Compliance Associates Inc., discusses the evolving relationship ...
Digital twins function as synchronized, real-time operational mirrors, where divergence from the physical process triggers ...
Ensuring data quality and harmonization transforms regulatory reporting from a compliance burden into a strategic asset, enabling confident decision-making and reducing compliance costs. Leveraging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results